Phase II study of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC): Longer follow-up. Rischin, D., Khushalani, N. I., Schmults, C. D., Guminski, A., Chang, A. S., Lewis, K. D., Lim, A., Hernandez-Aya, L., Hughes, B., Schadendorf, D., Hauschild, A., Stankevich, E., Booth, J., Li, S., Chen, Z., Okoye, E., Lowy, I., Fury, M. G., Migden, M. AMER SOC CLINICAL ONCOLOGY. 2020

View details for Web of Science ID 000560368300123